Jazz Pharmaceuticals, Inc. is a biopharmaceutical company that develops and sells prescription medicines. Their recent lobbying filings show they spent about $1.6 million (four filings) and focused mainly on pharmacy and FDA regulation of cannabis- and CBD-related therapies, plus issues tied to rare disease programs and certain agriculture or food laws. They used their in-house team for lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ms KARAS GROSS
The latest disclosures for this client.
JAZZ PHARMACEUTICALS, INC.
Q1JAZZ PHARMACEUTICALS, INC.
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
JAZZ PHARMACEUTICALS, INC.
MARK BOLTON
JAZZ PHARMACEUTICALS, INC.
VIRGINIA MCMILLIN
JAZZ PHARMACEUTICALS, INC.
JAZZ PHARMACEUTICALS, INC.
Q3JAZZ PHARMACEUTICALS, INC.
Q2JAZZ PHARMACEUTICALS, INC.
Q1